NOS2 and neoplasm: By elucidating the context-dependent effects of these agents across diverse immunological milieus, from inflammatory disorders to the tumor microenvironment, this work proposes a strategic framework for leveraging iNOS modulation in disease-specific macrophage reprogramming and immune intervention.